None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Patients scheduled to undergo transurethral resection of bladder tumor (TUR-BT) • Adult patients aged 19 years or older • Patients who have received a sufficient explanation regarding the purpose and procedures of the study and have provided written informed consent
Exclusion criteria
Exclusion criteria: • Patients with a prior diagnosis of urethral stricture • Patients with a history of undergoing transurethral resection of bladder tumor (TUR-BT). (However, the initial resection (Initial transurethral resection of bladder tumor) performed for confirmation of diagnosis and staging is excluded from this history.) • Patients scheduled for radical cystectomy • Patients with an active urinary tract infection (UTI) • Patients with neurogenic bladder • Patients who have undergone major lower urinary tract surgery within the last 3 months • Patients with an anticipated clinical condition that may affect the interpretation of study results, such as severe voiding dysfunction • Patients whose participation in the study is deemed clinically inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Confirmation of changes in the International Prostate Symptom Score (IPSS) voiding subscore | — |
Secondary
| Measure | Time frame |
|---|---|
| Confirmation of postoperative pain;duration of gross hematuria | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Seoul St. Mary's Hospital